Around the Web —12.01.22
The emergency use authorization (EUA) for bebtelovimab, the only COVID-19 antibody treatment remaining on the U.S. market, was withdrawn yesterday because of lack of efficacy
Michael Posey
December 1, 2022
The emergency use authorization (EUA) for bebtelovimab, the only COVID-19 antibody treatment remaining on the U.S. market, was withdrawn yesterday because of lack of efficacy
Healthcare professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse
In a phase 2b study, the oral agent ENT-01 was safe and significantly improved constipation and possibly neurologic symptoms in 150 participants with Parkinson disease
Eradication of Helicobacter pylori protects against peptic ulcer bleeding in older adults over the first couple of years, a study shows, but the effect appears
Adults with overweight and obesity who do not lose enough weight on lifestyle interventions alone should receive long-term pharmacotherapy with antiobesity medications (AOM) such as
Clinical Infectious Diseases: Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review Vaccine: Towards
Clinicians may be able to avoid the common practice of discontinuing anti–tumor necrosis factor (anti-TNF) treatment after 24 weeks of pregnancy in women with inflammatory
Visits to Ontario emergency departments (EDs) for cannabis hyperemesis syndrome (CHS) increased sharply in the years following the legalization of cannabis products in October 2019,